A Phase 2 Clinical Trial Investigating the Effects of Obeticholic Acid on Lipoprotein Metabolism in Subjects With Primary Biliary Cirrhosis
Phase of Trial: Phase II
Latest Information Update: 26 May 2017
Price : $35 *
At a glance
- Drugs Obeticholic acid (Primary)
- Indications Primary biliary cirrhosis
- Focus Therapeutic Use
- Sponsors Intercept Pharmaceuticals
- 28 Dec 2016 Status changed from active, no longer recruiting to completed.
- 12 Apr 2015 Planned primary completion date changed from 1 Aug 2016 to 1 Aug 2014 as reported by ClinicalTrials.gov record.
- 24 Mar 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Oct 2014 to 1 Oct 2016.